News | November 30, 2011

Infinitt’s Xelis Fusion Software Receives FDA Clearance

November 30, 2011 – Infinitt announced that its fusion software, Xelis Fusion, has received clearance from the U.S. Food and Drug Administration (FDA), and is now widely available to the North American market.

Xelis Fusion can be used as an integrated solution with Infinitt’s web-based picture archive and communications systems (PACS) or as a stand-alone solution, allowing any third-party PACS user to query, view and analyze studies from any digital imaging and communications in medicine (DICOM) database to do fusion of computed tomography (CT), positron emission tomography (PET) and magnetic resonance (MR) images.

According to the company, the Xelis Fusion product has been in use at 12 institutions across the United States and has demonstrated the ability to improve diagnosis and enhance the radiologist’s and clinician’s productivity. Edward Milman, M.D., director, MRI Services at St. Joseph's Regional Medical Center in Paterson, N.J., uses Xelis Fusion as a fully-integrated 3D application within the Infinitt PACS.

“I like Xelis Fusion because it integrates all the necessary tools to interpret a PET/CT,” Milman said. “I am able to access it directly from my PACS work list without third-party interference. There’s no need to interrupt the dictation. Key images are saved directly from the 3-D window into PACS and attached to the study to be accessed instantly.”

Xelis Fusion features:

·        Supports fusion of PET, CT and MR data in any combination of the modalities

·        Offers both automatic and manual registration methods, quantitative analysis tools and rapid image navigation using only a few mouse clicks

·        Supports 3-D region of interest (ROI) analysis

·        Provides a variety of presets and layouts for comparing two image sets

·        Calculates PET Standard Uptake Values (SUV)

·        Offers multiple standard and user-defined color maps

·        Stores/sends the fused images in DICOM 3.0 format

·        Includes integrated, freely-rotating MPR functions.

PET/CT Fusion is used primarily to assist in more accurate and reliable diagnosis of cancer, and is covered by most private insurance companies and by Medicare. Co-registration and alignment of different scans showing the same patient and pathology can add value to numerous image-based clinical review processes.

For more information: www.infinittna.com

Related Content

Technology | Focused Ultrasound Therapy | June 19, 2018
EDAP TMS SA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Focal One device for...
FDA Clears Bay Labs' EchoMD AutoEF Software for AI Echo Analysis
Technology | Cardiovascular Ultrasound | June 19, 2018
Cardiovascular imaging artificial intelligence (AI) company Bay Labs announced its EchoMD AutoEF software received 510(...
Report Finds Identifying Patients for Lung Cancer Screening Not So Simple
News | Lung Cancer | June 18, 2018
New findings in the current issue of The American Journal of Managed Care suggest that getting the right patients to...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Weight-Bearing CT International Study Group Hosts  Scientific Session at AOFAS Conference
News | Computed Tomography (CT) | June 15, 2018
June 15, 2018 —The Weight-Bearing CT International Study Group will host a scientific session on the benefits of weig
Florida Hospital First in State to Adopt NeuroLogica's BodyTom Elite CT
News | Computed Tomography (CT) | June 14, 2018
June 14, 2018 — NeuroLogica, a subsidiary of Samsung Electronics Co.
News | Remote Viewing Systems | June 14, 2018
International Medical Solutions (IMS) recently announced that the American College of Radiology (ACR) added IMS'...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Riverain Technologies Issued U.S. Patent for Vessel Suppression Technology
News | Computed Tomography (CT) | June 14, 2018
Riverain Technologies announced that the United States Patent and Trademark Office (USPTO) has awarded the company a...
360 Photos | 360 View Photos | June 14, 2018
This is a 360 degree image from the Canon Aquilion 64-slice...
Overlay Init